Your browser doesn't support javascript.
loading
Trivalent arsenicals induce skin toxicity through thiol depletion.
Hwang, Jee-Hyun; An, Gwang Jin; Kim, Chang-Hwan; Chung, Han Young; Lim, Kyung-Min.
Afiliación
  • Hwang JH; College of Pharmacy, Ewha Womans University, Seoul 03760, Republic of Korea.
  • An GJ; College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
  • Kim CH; Chem-Bio Technology Center, Agency for Defense Development, Republic of Korea.
  • Chung HY; College of Pharmacy, Chungnam National University, Daejeon 34134, Republic of Korea. Electronic address: hychung@cnu.ac.kr.
  • Lim KM; College of Pharmacy, Ewha Womans University, Seoul 03760, Republic of Korea. Electronic address: kmlim@ewha.ac.kr.
Toxicol Appl Pharmacol ; : 117115, 2024 Sep 30.
Article en En | MEDLINE | ID: mdl-39357682
ABSTRACT
Arsenic, a widespread environmental contaminant, is highly toxic to human health. Arsenic exposure is associated with the occurrence of skin lesions and diseases. This study investigated the dermal toxicity of trivalent arsenicals (AsIII and MMAIII) and its underlying mechanism using human keratinocyte cell line and ex vivo porcine skin. AsIII and MMAIII induced concentration-dependent cell apoptosis and necrosis in HaCaT cells, which was confirmed in ex vivo porcine skin. AsIII and MMAIII increased reactive oxygen species generation and GSH depletion. Interestingly, radical scavenger antioxidants such as Vitamin C failed to mitigate arsenic-induced cytotoxicity, while thiol-containing compounds effectively alleviated it, suggesting a key role of thiol depletion in the trivalent arsenical-induced dermal toxicity. DMSA showed the strongest protective effects against AsIII and MMAIII-induced cytotoxicity in HaCaT cells. Of note, DMSA restored arsenical-induced tissue damage, and reduced the apoptosis in ex vivo porcine skin, highlighting its potential use to alleviate arsenic-induced skin lesions and diseases.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Toxicol Appl Pharmacol Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Toxicol Appl Pharmacol Año: 2024 Tipo del documento: Article